Suppr超能文献

欧洲首例大环内酯耐药性犬恶丝虫——令人担忧的原因。

First case of macrocyclic lactone-resistant Dirofilaria immitis in Europe - Cause for concern.

作者信息

Traversa Donato, Diakou Anastasia, Colombo Mariasole, Kumar Sohini, Long Thavy, Chaintoutis Serafeim C, Venco Luigi, Betti Miller Gianluca, Prichard Roger

机构信息

Department of Veterinary Medicine, University of Teramo, 64100, Teramo, Italy.

Laboratory of Parasitology and Parasitic Diseases, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.

出版信息

Int J Parasitol Drugs Drug Resist. 2024 Aug;25:100549. doi: 10.1016/j.ijpddr.2024.100549. Epub 2024 May 21.

Abstract

Heartworm disease caused by the nematode Dirofilaria immitis is one of the most important parasitoses of dogs. The treatment of the infection is long, complicated, risky and expensive. Conversely, prevention is easy, safe, and effective and it is achieved by the administration of macrocyclic lactones (MLs). In recent years, D. immitis strains resistant to MLs have been described in Southern USA, raising concerns for possible emergence, or spreading in other areas of the world. The present study describes the first case of ML-resistant D. immitis in a dog in Europe. The dog arrived in Rome, Italy, from USA in 2023. Less than 6 months after its arrival in Italy, the dog tested positive for D. immitis circulating antigen and microfilariae, despite it having received monthly the ML milbemycin oxime (plus an isoxazoline) after arrival. The microfilariae suppression test suggested a resistant strain. Microfilariae DNA was examined by droplet digital PCR-based duplex assays targeting four marker positions at single nucleotide polymorphisms (SNP1, SNP2, SNP3, SNP7) which differentiate resistant from susceptible isolates. The genetic analysis showed that microfilariae had a ML-resistant genotype at SNP1 and SNP7 positions, compatible with a resistant strain. It is unlikely that the dog acquired the infection after its arrival in Europe, while it is biologically and epidemiologically plausible that the dog was already infected when imported from USA to Europe. The present report highlights the realistic risk of ML-resistant D. immitis strains being imported and possibly transmitted in Europe and other areas of the world. Monitoring dogs travelling from one area to another, especially if they originate from regions where ML-resistance is well-documented, is imperative. Scientists, practitioners, and pet owners should be aware of the risk and remain vigilant against ML-resistance, in order to monitor and reduce the spreading of resistant D. immitis.

摘要

由线虫犬恶丝虫引起的犬心丝虫病是犬类最重要的寄生虫病之一。该感染的治疗过程漫长、复杂、有风险且费用高昂。相反,预防措施简单、安全且有效,通过施用大环内酯类药物(MLs)即可实现。近年来,在美国南部已发现对MLs耐药的犬恶丝虫菌株,这引发了对其在世界其他地区可能出现或传播的担忧。本研究描述了欧洲首例对ML耐药的犬恶丝虫感染犬病例。这只狗于2023年从美国抵达意大利罗马。在抵达意大利不到6个月后,尽管它在抵达后每月都接受了ML米尔贝霉素肟(加一种异恶唑啉)治疗,但检测发现其犬恶丝虫循环抗原和微丝蚴呈阳性。微丝蚴抑制试验表明存在耐药菌株。通过基于液滴数字PCR的双链分析检测微丝蚴DNA,该分析针对单核苷酸多态性的四个标记位置(SNP1、SNP2、SNP3、SNP7),可区分耐药和敏感分离株。基因分析表明,微丝蚴在SNP1和SNP7位置具有ML耐药基因型,与耐药菌株相符。这只狗在抵达欧洲后感染的可能性不大,而从生物学和流行病学角度来看,它在从美国进口到欧洲时就已经感染则是合理的。本报告强调了对ML耐药的犬恶丝虫菌株被进口并可能在欧洲和世界其他地区传播的现实风险。监测从一个地区前往另一个地区的犬只,特别是如果它们来自ML耐药情况有充分记录的地区,势在必行。科学家、从业者和宠物主人应意识到这种风险,并对ML耐药保持警惕,以便监测和减少耐药犬恶丝虫的传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a381/11153229/04169f83ff41/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验